Abstract
1 Brotizolam, a triazolo-1,4-thienodiazepine, was studied in healthy young adults. Electroencephalographic sleep variables and subjective effects, and performance on a visuo-motor coordination task were measured. 2 In the sleep studies six males each ingested 0.2, 0.4 and 0.6 mg brotizolam overnight. All doses increased total sleep time, improved the sleep efficiency index, and reduced drowsy sleep and number of awakenings. Brotizolam 0.4 and 0.6 mg also reduced awake activity and increased stage 2 sleep. There was some evidence of a delay to the first REM period, but only 0.6 mg reduced the total duration of REM sleep. There were no changes in slow wave sleep. 3. In the performance studies six females each ingested 0.4 mg in the morning and 0.2, 0.4 and 0.6 mg brotizolam at night. After morning ingestion of 0.4 mg there was impaired performance from 0.5 to 5.5 h. There were no residual effects after 0.2 mg brotizolam, but with 0.4 mg there was a residual effect at 9.5 h, and 0.6 mg led to impairments up to 15.0 h after ingestion. 4 Brotizolam is a short-acting hypnotic. In doses around 0.2 mg it has useful hypnotic activity free of adverse effects on sleep and residual effects on performance. With 0.4 mg the hypnotic effect is enhanced with only minimal residual effects.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borland R. G., Nicholson A. N. Comparison of the residual effects of two benzodiazepines (nitrazepam and flurazepam hydrochloride) and pentobarbitone sodium on human performance. Br J Clin Pharmacol. 1975 Feb;2(1):9–17. doi: 10.1111/j.1365-2125.1975.tb00465.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicholson A. N., Stone B. M. Activity of the hypnotics, flunitrazepam and triazolam, in man. Br J Clin Pharmacol. 1980 Feb;9(2):187–194. doi: 10.1111/j.1365-2125.1980.tb05832.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicholson A. N., Stone B. M. L-tryptophan and sleep in healthy man. Electroencephalogr Clin Neurophysiol. 1979 Nov;47(5):539–545. doi: 10.1016/0013-4694(79)90255-4. [DOI] [PubMed] [Google Scholar]
- Roth T., Kramer M., Lutz T. Intermediate use of triazolam: a sleep laboratory study. J Int Med Res. 1976;4(1):59–63. doi: 10.1177/030006057600400109. [DOI] [PubMed] [Google Scholar]
- Saletu B., Grünberger J., Volavka J., Berner P. Classification and bioavailability studies with WE 941 by quantitative pharmaco-EEG and clinical analyses. Arzneimittelforschung. 1979;29(4):700–704. [PubMed] [Google Scholar]